Peter Vranes is a Co-founder of Nutromics, an Australian med-tech company providing continuous, real-time molecular monitoring using a smart patch biosensor platform. In this episode, Peter shares his story from having already built and exited a successful cosmeceutical brand and how that led to meeting his co-founder to build Nutromics. He also talks about how that experience led to them participating in a med-tech accelerator, and their journey through capital raising and proof of concepts.


Key takeaways:

  1. Conventional molecular tests and monitoring leaves big gaps in terms of the information needed to support decision making (especially where monitoring of fast-moving molecular targets is needed).
  2. Nutromics has developed a one patch platform that can be adapted to many applications and can ensure, continuously and in real-time, that a patient is receiving a dose at the right time and level to stay within the therapeutic range.
  3. The molecular sensing technology has a microneedle array platform and an aptamer sensor platform that promises flexibility for this Smart Patch to be used in many different therapeutic contexts.


Resources and links:



Never miss an episode
Get new episodes delivered automatically to your device as soon as
they're released by subscribing below with your preferred podcast player.

If you like the podcast don't forget to give it a 5 start rating and a share,
it really helps others find the show.
Want to be a Guest?